Bacterial Infections
📧 Sign up to get email alerts when something new happens for Bacterial Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Trial of Rapid Diagnostic Tests in Rural Ghana [Phase 4]
A Phase 4 trial update from the London School of Hygiene and Tropical Medicine reports completion of a study evaluating rapid diagnostic tes…
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial [NA]
A randomized diagnostic trial comparing MALDI-TOF mass spectrometry to routine clinical microbiology for identifying bacterial and fungal pa…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) [Phase 1]
Phase 1 safety and tolerability trial of aztreonam-avibactam (ATM-AVI) in complicated infections has completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile [Phase 1]
This Phase 1 trial update reports safety and pharmacokinetics data for clindamycin in pediatric subjects with BMI at or above the 85th perce…
-
CLINICAL_TRIALS trial_result · 2016-10-13Clinical Trial Update: Local Collagen-Gentamicin and Extra Fixation of the Sternum for Prevention of Sternal Wound Infection in Cardiac Surgery [NA]
This completed clinical trial evaluated using a collagen-Gentamicin local application with extra sternum fixation to prevent sternal wound i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Early Procalcitonin Kinetics During Empirical Antibiotic Therapy in Critically Ill Patients
This ClinicalTrials.gov entry reports on a completed study evaluating procalcitonin kinetics during empirical antibiotic therapy in critical…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA) [Phase 1]
Phase 1 study reports ascending-dose pharmacokinetics and absolute bioavailability for an antibiotic developed by Trius Therapeutics (a Merc…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) [Phase 3]
Phase 3 clinical trial update for V419 given with Prevnar 13 and RotaTeq; study completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) [Phase 3]
Phase 3 clinical trial update on V419 given with Prevnar 13 and RotaTeq, focusing on safety, tolerability, and immunogenicity; study complet…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients [Phase 1, Phase 2]
Phase 1/Phase 2 trials evaluating the safety and preliminary efficacy of a topical antibacterial protein molecule applied to the nostrils in…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.
The clinical trial investigating how ceftriaxone and/or fluoroquinolone treatment affects gut microbiota in hospitalized patients has been t…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002) [Phase 2]
Merck's investigational vaccine V419-002 completed Phase 2 testing in infants, evaluating safety and effectiveness for bacterial and viral i…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003) [Phase 2]
Phase 2 study assessing the safety and tolerability of V419 in healthy infants at 2, 4, 6, and 12-14 months of age.
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants [Phase 4]
Phase 4 safety update evaluating fluconazole treatment in premature and full-term newborn infants.
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Effect of Xylitol on Oral Microbiota in Children [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated the effect of xylitol on the oral microbiota in children; the study is completed with results pos…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years. [Phase 1]
A Phase 1 pharmacokinetics and safety study of dalbavancin in hospitalized children aged 3 months to 11 years has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers [Phase 1]
A Phase 1 multiple-dose study of Debio 1450 in healthy volunteers (administered intravenously or orally) sponsored by Debiopharm Internation…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults [Phase 3]
Phase 3 clinical trial update assessing the immunogenicity and safety of GC1107 administered intramuscularly in healthy adults for bacterial…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children [Phase 2, Phase 3]
This study evaluated the immunogenicity and safety of GC1107 administered intramuscularly in healthy children in Phase 2/3; the trial has co…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics
Completed clinical trial WEUKBRE5555 under the IMI PROTECT program evaluating liver injury in antibiotic use for bacterial infections.
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation
This clinical trial update reports the termination of a validation study evaluating combined PET/CT imaging for diagnosing infection and inf…
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: A Single Dose Study of Debio 1450 in Healthy Subjects [Phase 1]
Phase 1 trial evaluating a single dose of Debio 1450 in healthy subjects has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months
This completed trial evaluated whether procalcitonin can predict serious bacterial infection in infants under 3 months. The study status is …
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects [Phase 1]
Phase 1 study assessing safety, tolerability, and pharmacokinetics of intravenous RPX2014 and RPX7009 in healthy adults; the trial has compl…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards [NA]
This completed trial evaluated how clinical pharmacist interventions affect antibiotic prescribing and related costs on surgical wards.